Arqt stock forecast.

Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...

Arqt stock forecast. Things To Know About Arqt stock forecast.

ARQT stock had an impressive performance on November 6, 2023, based on the information provided by CNN Money. The 12-month price forecasts from 8 analysts for Arcutis Biotherapeutics Inc had a median target of $21.00, with a high estimate of $50.00 and a low estimate of $4.00.Find real-time ARCT - Arcturus Therapeutics Holdings Inc stock quotes, company profile, news and forecasts from CNN Business.Find the latest Taysha Gene Therapies, Inc. (TSHA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Current. -$1.05. 1 Month Ago. -$1.17. 3 Months Ago. -$1.15. Arcutis Biotherapeutics Inc. analyst estimates, including ARQT earnings per share estimates and analyst recommendations.

Valuation ; FCF Yield, -12,0%, -24,1% ; Price to Book, -, 3,50x ; Nbr of stocks (in thousands), 43 566, 50 295 ; Reference price · 28,1, 20,7 ...

Nov 28, 2023 · Stock Price Forecast. According to 8 stock analysts, the average 12-month stock price forecast for ARQT stock stock is $33.38, which predicts an increase of 1,268.03%. The lowest target is $4.00 and the highest is $50. On average, analysts rate ARQT stock stock as a strong buy. ARQT has an Altman Z-Score of -5.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Arcutis Biotherapeutics, Inc. (ARQT) stock, including valuation metrics, financial numbers, share information and more.

Current. -$1.05. 1 Month Ago. -$1.17. 3 Months Ago. -$1.15. Arcutis Biotherapeutics Inc. analyst estimates, including ARQT earnings per share estimates and analyst recommendations.Dec 1, 2023 · 9 analysts have issued twelve-month target prices for Arcutis Biotherapeutics' shares. Their ARQT share price targets range from $6.00 to $57.00. On average, they anticipate the company's stock price to reach $29.67 in the next year. This suggests a possible upside of 1,390.8% from the stock's current price. Arcutis Biotherapeutics (ARQT) stock price prediction is 1.0118522608668 USD. The Arcutis Biotherapeutics stock forecast is 1.0118522608668 USD for 2024 November 09, Saturday with technical analysis. Find the latest Verve Therapeutics, Inc. (VERV) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...

Forecast for 2023 Dec. is $1.92, for 2024 Nov. is $2.34, for 2027 Nov. is $4.18, for 2028 Nov. is $4.18, and for 2032 Nov. is $4.18. See more forecasts. Tudal. U.S. Stock Market Prediction U.S. Stock Forecast Tomorrow World Stock Markets ETF Market Prediction ETF Forecast Tomorrow Cryptocurrency Prediction Forex Market Prediction Currency ...

Nov 3, 2023 · ARQT has an Altman Z-Score of -5.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Arcutis Biotherapeutics, Inc. (ARQT) stock, including valuation metrics, financial numbers, share information and more.

Arcutis Biotherapeutics lowest stock price was $1.77 and its highest was $18.19 in the past 12 months. What is Arcutis Biotherapeutics’s market cap? Currently, no data AvailableThe consensus price target of analysts on Wall Street is $36.63, which implies an increase of 91.73% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6.00 and $57.00 respectively. As a result, ARQT is trading at a discount of -1781.19% off the target high and -98.02% off the low.Within the last quarter, Arcutis Biotherapeutics (NASDAQ:ARQT) has observed the following analyst ratings: In the last 3 months, 7 analysts have offered 12-month price targets for Arcutis ...View Arcutis Biotherapeutics, Inc ARQT investment & stock information. Get the latest Arcutis Biotherapeutics, Inc ARQT detailed stock quotes, stock data, Real …Arcutis Biotherapeutics' CEO is Frank Watanabe, appointed in Jan 2016, has a tenure of 7.83 years. total yearly compensation is $4.58M, comprised of 12.9% salary and 87.1% bonuses, including company stock and options. directly owns 0.45% of the company’s shares, worth $798.75K. The average tenure of the management team and the board of ...

Amazon Stock Forecast. All Analysts Top Analysts Stock Price Forecast. According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy.Arcutis Biotherapeutics Inc Ordinary Shares ARQT Morningstar Rating Stock XNAS Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials...3 Wall Street research analysts have issued 1-year price targets for TF Financial's stock. Their THRD share price targets range from $3.60 to $7.00. On average, they predict the company's stock price to reach $5.30 in the next twelve months. This suggests that the stock has a possible downside of 15.7%.Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -26.50M. 66.61%. Get the latest Arcutis Biotherapeutics Inc (ARQT) real-time quote ... As of May 30, 2023, 4:00 PM CST, Arcutis Biotherapeutics Inc’s stock price was $7.81. Arcutis Biotherapeutics Inc is down 7.02% from its previous closing price of $8.40. During the last market session, Arcutis Biotherapeutics Inc’s stock traded between $8.11 and $8.57. Currently, there are 61.17 million shares of Arcutis Biotherapeutics Inc ...

Stock Screener; ETF Screener; Comparisons; ... FREQ, ARQT and ADTX among healthcare movers. ... Salesforce rallies on strong forecasts, earnings Yesterday, ...

Nov 6, 2023 · According to the data, eight analysts have offered their 12-month price forecasts for ARQT stock. The median target price is $21.00, with a high estimate of $50.00 and a low estimate of $4.00. This indicates a potential increase of 762.42% from the last recorded price of $2.44. Furthermore, the current consensus among the eight polled ... 13 нояб. 2023 г. ... On November 13, 2023, ARQT stock showed mixed performance, with a slight decrease in the opening price compared to the previous close. The stock ...Shares of ARQT fell 6.9% in extended trading. ARQT added that it intends to grant the underwriters a 30-day option to purchase up to an additional $15M of its common shares. Press ReleaseTheir ORCL share price targets range from $93.00 to $150.00. On average, they anticipate the company's share price to reach $124.23 in the next year. This suggests a possible upside of 6.9% from the stock's current price. View analysts price targets for ORCL or view top-rated stocks among Wall Street analysts.Our algorithm forecasts the stock price of Arcutis Biotherapeutics Inc with the highest accuracy in the market. Intratio forecasts every day all US-listed ...As of May 30, 2023, 4:00 PM CST, Arcutis Biotherapeutics Inc’s stock price was $7.81. Arcutis Biotherapeutics Inc is down 7.02% from its previous closing price of $8.40. During the last market session, Arcutis Biotherapeutics Inc’s stock traded between $8.11 and $8.57. Currently, there are 61.17 million shares of Arcutis Biotherapeutics Inc ...beststocks.comArcutis Biotherapeutics ARQT is set to give its latest quarterly earnings report on Tuesday, 2023-02-28. Here's what investors need to know before the announcement. Analysts estimate that Arcutis ...Nov 6, 2023 · Analyst projections state that ARQT is forecast to be at a low of $4.00 and a high of $50.00. In order for the stock price to hit the forecast high, the stock would need to plunge -1949.18% from its current level, while the stock would need to crash -63.93% from its current level to reach the projected low.

MARA | Complete Marathon Digital Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Dec 1, 2023 · Stock analysis for Arcutis Biotherapeutics Inc (ARQT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

2 days ago · The latest Arcutis Biotherapeutics stock prices, stock quotes, news, and ARQT history to help you invest and trade smarter. ... The 32 analysts offering price forecasts for Arcutis Biotherapeutics ... ARQT Stock Predictions, Articles, and Arcutis Biotherapeutics Inc News From InvestorPlace From the Web Jones Research downgrades Arcutis to hold, cites loan agreement (ARQT) From Seeking Alpha ...Today's High; $2.00: Today's Low; $1.76: 52 Week High; $18.04: 52 Week Low; $1.76. ARQT. Technical Analysis. Overlays. Simple Moving Average (SMA).Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.DraftKings shares gained 16.5% to close at $33.75 on Friday. See how other analysts view this stock. Keybanc cut the price target for Restaurant Brands International Inc. (NYSE:QSR) from $85 to ...Nov 29, 2023 · Arcutis Biotherapeutics, Inc. (ARQT) Loses -51.27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner. 10/31/23-8:35AM EST Zacks. Represents the company's profit divided by the outstanding shares of its common stock. Fiscal Q4 2023 ended 9/30/23. Fiscal Q4 2023 ended 9/30/23. Get the latest Arqit Quantum Inc (ARQQ) real-time ...According to . 1 Wall Street analyst that have issued a 1 year THRD price target, the average THRD price target is $7.00, with the highest THRD stock price forecast at $7.00 and the lowest THRD stock price forecast at $7.00.Created with Sketch. Market Activity. Funds + ETFs. research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period ...Arcutis Biotherapeutics Inc Follow Share $1.90 After Hours: $1.91 (0.53%) +0.0100 Closed: Nov 29, 7:17:41 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Immunitybio Inc $3.98 IBRX1.49%...

As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...Mumbai Stock Forecast . Bombay Stock Exchange Stock Forecast BSE Share Price Predictions with Smart Prognosis Chart - 2023-2024 You can find here the Best Indian Stocks to buy! Showing 1-100 of 3,290 items. Forecast Range Filter. From % To % Filter Reset / Default. Rating Name Price (INR) ...Instagram:https://instagram. options alerts servicemicrosoft ex dividend datef.tvwebull competitors Arcutis Biotherapeutics Inc Ordinary Shares ARQT Morningstar Rating Stock XNAS Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials...Arcutis Biotherapeutics Stock Price, News & Analysis (NASDAQ:ARQT) $1.99 +0.15 (+8.15%) (As of 12/1/2023 ET) Compare Today's Range $1.76 $2.00 50-Day Range $1.84 $5.83 52-Week Range $1.76 $18.04 Volume 2.93 million shs Average Volume 2.67 million shs Market Capitalization $187.82 million P/E Ratio N/A Dividend Yield gld exchangecolumbus financial advisors 17 equities research analysts have issued 12 month price targets for Pfizer's stock. Their PFE share price targets range from $33.00 to $75.00. On average, they predict the company's share price to reach $42.50 in the …Find real-time ARCT - Arcturus Therapeutics Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. is silver undervalued Arcutis Biotherapeutics has just announced that the FDA has given its stamp of approval on the supplemental new drug application (sNDA) for ZORYVE (roflumilast) cream 0.3%. This approval expands the indication of ZORYVE to include the topical treatment of plaque psoriasis, including intertriginous areas, in children aged 6 to 11 …Oct 24, 2023 · Celebrations may be in order for Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company.The ...